Inflammatory signatures in older persons with physical frailty and sarcopenia

The frailty “cytokinome” at its core

Emanuele Marzetti, Anna Picca, Federico Marini, Alessandra Biancolillo, Hélio José Coelho-Junior, Jacopo Gervasoni, Maurizio Bossola, Matteo Cesari, Graziano Onder, Francesco Landi, Roberto Bernabei, Riccardo Calvani

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The construct of physical frailty and sarcopenia (PF&S) identifies an age-related pre-disability condition defined by reduced physical performance and low muscle mass. Whether PF&S is characterized by perturbations of the cytokine network is presently unclear. Furthermore, the existence of gender-specific inflammatory profiles of PF&S is unknown. This study was designed to explore the association between a large panel of inflammatory biomolecules and PF&S in older adults through a multivariate statistical approach. Gender-specific inflammatory patterns were also explored. Methods: One-hundred community-dwellers aged 70 years and older with PF&S and 100 non-sarcopenic, non-frail controls (nonPF&S) were enrolled. A panel of 30 circulating inflammatory biomarkers was assayed. Partial least squares discriminant analysis (PLS-DA) was employed to explore the relationship between inflammatory molecules and PF&S. Separate PLS-DA models were built for the whole sample and the two genders. Double cross-validation procedures were used to validate the predictive ability of PLS-DA models. Results: The optimal complexity of the PLS-DA model built on the whole sample was found to be four latent variables. The proportion of correct classification was 75.6 ± 1.3% (82.3 ± 1.6% for enrollees with PF&S and 68.7 ± 2.5% for nonPF&S controls). The inflammatory profile of people with PF&S was defined by higher levels of P-selectin, C-reactive protein (CRP), and interferon γ-induced protein 10. NonPF&S participants were characterized by higher levels of myeloperoxidase (MPO), interleukin (IL) 8, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-α, platelet-derived growth factor (PDGF) BB. Gender-specific PLS-DA allowed identifying a “core” inflammatory signature of PF&S, composed by higher levels of CRP, and lower concentrations of MPO, IL8, MCP-1, and PDGF-BB, with peculiar patterns of relationships for men and women. Conclusions: A core inflammatory profile was identified in people with PF&S with a gender-specific signature. The dissection of the PF&S “cytokinome” will provide novel insights into the role played by inflammation in the disabling cascade and allow designing personalized treatment strategies.

Original languageEnglish
Pages (from-to)129-138
Number of pages10
JournalExperimental Gerontology
Volume122
DOIs
Publication statusPublished - Jul 15 2019

Fingerprint

Sarcopenia
Discriminant Analysis
Discriminant analysis
Least-Squares Analysis
Chemokine CCL2
Interleukin-8
C-Reactive Protein
Peroxidase
Macrophage Inflammatory Proteins
Dissection
P-Selectin
Biomolecules
Biomarkers
Interferons
Muscle
Association reactions
Cytokines
Inflammation
Muscles
Molecules

Keywords

  • Aging
  • Biomarkers
  • Cytokines
  • Inflammaging
  • Multi-block partial least squares - discriminant analysis
  • Physical performance

ASJC Scopus subject areas

  • Biochemistry
  • Ageing
  • Molecular Biology
  • Genetics
  • Endocrinology
  • Cell Biology

Cite this

Inflammatory signatures in older persons with physical frailty and sarcopenia : The frailty “cytokinome” at its core. / Marzetti, Emanuele; Picca, Anna; Marini, Federico; Biancolillo, Alessandra; Coelho-Junior, Hélio José; Gervasoni, Jacopo; Bossola, Maurizio; Cesari, Matteo; Onder, Graziano; Landi, Francesco; Bernabei, Roberto; Calvani, Riccardo.

In: Experimental Gerontology, Vol. 122, 15.07.2019, p. 129-138.

Research output: Contribution to journalArticle

@article{ce79418417f7490faa0984aa1043f1dd,
title = "Inflammatory signatures in older persons with physical frailty and sarcopenia: The frailty “cytokinome” at its core",
abstract = "Background: The construct of physical frailty and sarcopenia (PF&S) identifies an age-related pre-disability condition defined by reduced physical performance and low muscle mass. Whether PF&S is characterized by perturbations of the cytokine network is presently unclear. Furthermore, the existence of gender-specific inflammatory profiles of PF&S is unknown. This study was designed to explore the association between a large panel of inflammatory biomolecules and PF&S in older adults through a multivariate statistical approach. Gender-specific inflammatory patterns were also explored. Methods: One-hundred community-dwellers aged 70 years and older with PF&S and 100 non-sarcopenic, non-frail controls (nonPF&S) were enrolled. A panel of 30 circulating inflammatory biomarkers was assayed. Partial least squares discriminant analysis (PLS-DA) was employed to explore the relationship between inflammatory molecules and PF&S. Separate PLS-DA models were built for the whole sample and the two genders. Double cross-validation procedures were used to validate the predictive ability of PLS-DA models. Results: The optimal complexity of the PLS-DA model built on the whole sample was found to be four latent variables. The proportion of correct classification was 75.6 ± 1.3{\%} (82.3 ± 1.6{\%} for enrollees with PF&S and 68.7 ± 2.5{\%} for nonPF&S controls). The inflammatory profile of people with PF&S was defined by higher levels of P-selectin, C-reactive protein (CRP), and interferon γ-induced protein 10. NonPF&S participants were characterized by higher levels of myeloperoxidase (MPO), interleukin (IL) 8, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-α, platelet-derived growth factor (PDGF) BB. Gender-specific PLS-DA allowed identifying a “core” inflammatory signature of PF&S, composed by higher levels of CRP, and lower concentrations of MPO, IL8, MCP-1, and PDGF-BB, with peculiar patterns of relationships for men and women. Conclusions: A core inflammatory profile was identified in people with PF&S with a gender-specific signature. The dissection of the PF&S “cytokinome” will provide novel insights into the role played by inflammation in the disabling cascade and allow designing personalized treatment strategies.",
keywords = "Aging, Biomarkers, Cytokines, Inflammaging, Multi-block partial least squares - discriminant analysis, Physical performance",
author = "Emanuele Marzetti and Anna Picca and Federico Marini and Alessandra Biancolillo and Coelho-Junior, {H{\'e}lio Jos{\'e}} and Jacopo Gervasoni and Maurizio Bossola and Matteo Cesari and Graziano Onder and Francesco Landi and Roberto Bernabei and Riccardo Calvani",
year = "2019",
month = "7",
day = "15",
doi = "10.1016/j.exger.2019.04.019",
language = "English",
volume = "122",
pages = "129--138",
journal = "Experimental Gerontology",
issn = "0531-5565",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Inflammatory signatures in older persons with physical frailty and sarcopenia

T2 - The frailty “cytokinome” at its core

AU - Marzetti, Emanuele

AU - Picca, Anna

AU - Marini, Federico

AU - Biancolillo, Alessandra

AU - Coelho-Junior, Hélio José

AU - Gervasoni, Jacopo

AU - Bossola, Maurizio

AU - Cesari, Matteo

AU - Onder, Graziano

AU - Landi, Francesco

AU - Bernabei, Roberto

AU - Calvani, Riccardo

PY - 2019/7/15

Y1 - 2019/7/15

N2 - Background: The construct of physical frailty and sarcopenia (PF&S) identifies an age-related pre-disability condition defined by reduced physical performance and low muscle mass. Whether PF&S is characterized by perturbations of the cytokine network is presently unclear. Furthermore, the existence of gender-specific inflammatory profiles of PF&S is unknown. This study was designed to explore the association between a large panel of inflammatory biomolecules and PF&S in older adults through a multivariate statistical approach. Gender-specific inflammatory patterns were also explored. Methods: One-hundred community-dwellers aged 70 years and older with PF&S and 100 non-sarcopenic, non-frail controls (nonPF&S) were enrolled. A panel of 30 circulating inflammatory biomarkers was assayed. Partial least squares discriminant analysis (PLS-DA) was employed to explore the relationship between inflammatory molecules and PF&S. Separate PLS-DA models were built for the whole sample and the two genders. Double cross-validation procedures were used to validate the predictive ability of PLS-DA models. Results: The optimal complexity of the PLS-DA model built on the whole sample was found to be four latent variables. The proportion of correct classification was 75.6 ± 1.3% (82.3 ± 1.6% for enrollees with PF&S and 68.7 ± 2.5% for nonPF&S controls). The inflammatory profile of people with PF&S was defined by higher levels of P-selectin, C-reactive protein (CRP), and interferon γ-induced protein 10. NonPF&S participants were characterized by higher levels of myeloperoxidase (MPO), interleukin (IL) 8, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-α, platelet-derived growth factor (PDGF) BB. Gender-specific PLS-DA allowed identifying a “core” inflammatory signature of PF&S, composed by higher levels of CRP, and lower concentrations of MPO, IL8, MCP-1, and PDGF-BB, with peculiar patterns of relationships for men and women. Conclusions: A core inflammatory profile was identified in people with PF&S with a gender-specific signature. The dissection of the PF&S “cytokinome” will provide novel insights into the role played by inflammation in the disabling cascade and allow designing personalized treatment strategies.

AB - Background: The construct of physical frailty and sarcopenia (PF&S) identifies an age-related pre-disability condition defined by reduced physical performance and low muscle mass. Whether PF&S is characterized by perturbations of the cytokine network is presently unclear. Furthermore, the existence of gender-specific inflammatory profiles of PF&S is unknown. This study was designed to explore the association between a large panel of inflammatory biomolecules and PF&S in older adults through a multivariate statistical approach. Gender-specific inflammatory patterns were also explored. Methods: One-hundred community-dwellers aged 70 years and older with PF&S and 100 non-sarcopenic, non-frail controls (nonPF&S) were enrolled. A panel of 30 circulating inflammatory biomarkers was assayed. Partial least squares discriminant analysis (PLS-DA) was employed to explore the relationship between inflammatory molecules and PF&S. Separate PLS-DA models were built for the whole sample and the two genders. Double cross-validation procedures were used to validate the predictive ability of PLS-DA models. Results: The optimal complexity of the PLS-DA model built on the whole sample was found to be four latent variables. The proportion of correct classification was 75.6 ± 1.3% (82.3 ± 1.6% for enrollees with PF&S and 68.7 ± 2.5% for nonPF&S controls). The inflammatory profile of people with PF&S was defined by higher levels of P-selectin, C-reactive protein (CRP), and interferon γ-induced protein 10. NonPF&S participants were characterized by higher levels of myeloperoxidase (MPO), interleukin (IL) 8, monocyte chemoattractant protein 1 (MCP-1), macrophage inflammatory protein 1-α, platelet-derived growth factor (PDGF) BB. Gender-specific PLS-DA allowed identifying a “core” inflammatory signature of PF&S, composed by higher levels of CRP, and lower concentrations of MPO, IL8, MCP-1, and PDGF-BB, with peculiar patterns of relationships for men and women. Conclusions: A core inflammatory profile was identified in people with PF&S with a gender-specific signature. The dissection of the PF&S “cytokinome” will provide novel insights into the role played by inflammation in the disabling cascade and allow designing personalized treatment strategies.

KW - Aging

KW - Biomarkers

KW - Cytokines

KW - Inflammaging

KW - Multi-block partial least squares - discriminant analysis

KW - Physical performance

UR - http://www.scopus.com/inward/record.url?scp=85065622344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065622344&partnerID=8YFLogxK

U2 - 10.1016/j.exger.2019.04.019

DO - 10.1016/j.exger.2019.04.019

M3 - Article

VL - 122

SP - 129

EP - 138

JO - Experimental Gerontology

JF - Experimental Gerontology

SN - 0531-5565

ER -